Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Next Science Ltd ( (AU:NXS) ) has shared an announcement.
Next Science Limited has applied to be voluntarily removed from the ASX official list after completing the sale of substantially all of its assets to OSARTIS GmbH in September 2025, leaving the company without ongoing operations or plans for new business activity. The company plans to undertake an equal capital reduction to return most of the transaction proceeds to shareholders, retain a portion to cover the costs of the capital return, delisting, and an orderly voluntary winding up of the group, and then proceed to delist and commence liquidation, subject to shareholder approval at an extraordinary general meeting scheduled for 28 January 2026 and ASX consent, with an indicative delisting date of 13 February 2026. The board argues that ongoing listing, compliance and administrative costs would unnecessarily erode the final distribution to investors, and that delisting will maximise remaining value for shareholders as the company is effectively winding down rather than seeking new capital or growth opportunities.
The most recent analyst rating on (AU:NXS) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Next Science Ltd stock, see the AU:NXS Stock Forecast page.
More about Next Science Ltd
Next Science Limited is an Australian healthcare company that has focused on developing and commercialising medical technologies, with its operations historically conducted through the Next Science Group and its wholly owned subsidiaries. Following the sale of substantially all of its assets to OSARTIS GmbH, a Demetra company, Next Science no longer has ongoing business operations and does not plan to enter new business activities, effectively transitioning from an operating growth company to a vehicle for returning capital to shareholders and winding up its affairs.
Average Trading Volume: 232,616
Technical Sentiment Signal: Sell
Current Market Cap: A$40.97M
For detailed information about NXS stock, go to TipRanks’ Stock Analysis page.